Simon Feldbæk Nielsen

This inventor holds 13 USPTO granted patents and 12 EPO patents. Top assignees: Leo-Pharma A/s, Lica Pharmaceuticals A/s, Neurosearch A/s. Active years: 2006-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Simon Feldbæk Nielsen. Retrieved from https://idiyas.com/inventor/simon-feldbæk-nielsen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13

% Patents Active = 15.4

EPO Patents = 12 (Patent Applications = 11)

Average Co-Inventor Count = 2.8

ph-index = 3

Forward Citations = 17(Granted Patents)

Location History:

Herlev, DK (2006 - 2016)
Ballerup, DK (2015 - 2016)

Company Filing History:

Lica Pharmaceuticals A/s

Years Active: 2006-2016

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9346809 - Heterocyclic compounds as JAK receptor and protein tyrosine kinase inhibitors (2016-05-24),

2. 9233964 - Sulfamide piperazine derivatives as protein tyrosine kinase inhibitors and pharmaceutical use therof (2016-01-12),

3. 9051290 - Biaryl phosphodiesterase inhibitors (2015-06-09),

4. 8980905 - Benzodioxole or benzodioxepine heterocyclic compounds as phosphodiesterase inhibitors (2015-03-17),

5. 8952162 - Triazolopyridines as phosphodiesterase inhibitors for treatment of dermal diseases (2015-02-10),

6. 8940761 - [1,2,4]triazolopyridines and their use as phosphodiesterase inhibitors (2015-01-27),

7. 8497380 - Substituted acetophenones useful as PDE4 inhibitors (2013-07-30),

8. 8338431 - Phosphodiesterase inhibitors (2012-12-25),

9. 8324394 - Substituted acetophenones useful as PDE4 inhibitors (2012-12-04),

10. 8148537 - Substituted acetophenones useful as PDE4 inhibitors (2012-04-03),

11. 7642367 - Diamino-functional chalcones (2010-01-05),

12. 7423181 - Aminoalkoxy-functional chalcones (2008-09-09),

13. 7060699 - Aryl and heteroaryl diazabicycloalkanes, their preparation and use (2006-06-13),

Title: Innovations and Contributions of Simon Feldbæk Nielsen

Introduction

Simon Feldbæk Nielsen is a notable inventor based in Herlev, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as inhibitors for various diseases. With a total of 13 patents to his name, his work has the potential to impact numerous therapeutic areas.

Latest Patents

Among his latest patents, Nielsen has developed heterocyclic compounds that act as JAK receptor and protein tyrosine kinase inhibitors. These compounds are designed for therapeutic use in treating conditions such as psoriasis, atopic dermatitis, lupus, multiple sclerosis, and various cancers. Another significant patent involves sulfamide piperazine derivatives, which also function as protein tyrosine kinase inhibitors. These inventions aim to provide new treatment options for autoimmune diseases and conditions requiring immunosuppression, such as organ transplantation.

Career Highlights

Throughout his career, Simon Feldbæk Nielsen has worked with prominent companies in the pharmaceutical industry, including Leo Pharma A/S and Lica Pharmaceuticals A/S. His experience in these organizations has allowed him to refine his expertise in drug development and innovation.

Collaborations

Nielsen has collaborated with several professionals in his field, including colleagues such as Jakob Felding and Jens Christian Højland Larsen. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Simon Feldbæk Nielsen's contributions to pharmaceutical innovation are noteworthy, particularly in the realm of disease treatment through novel compounds. His extensive patent portfolio reflects his commitment to advancing medical science and improving patient outcomes.

Profile summary based on public USPTO records.